Prognostic Value of Plasma hPG<sub>80</sub> (Circulating Progastrin) in Metastatic Renal Cell Carcinoma.

导出 OA

翻译打印收藏纠错

第一作者： Manish,Kohli

第一单位： Division of Oncology, Department of Medicine, Huntsman Cancer Institute, 2000 Circle of Hope Dr., Salt Lake City, UT 84112, USA.

作者： Manish,Kohli ^[1] ; Winston,Tan ^[2] ; Bérengère,Vire ^[3] ; Pierre,Liaud ^[3] ; Mélina,Blairvacq ^[3] ; Frederic,Berthier ^[4] ; Daniel,Rouison ^[4] ; George,Garnier ^[4] ; Léa,Payen ^[5] ; Thierry,Cousin ^[6] ; Dominique,Joubert ^[6] ; Alexandre,Prieur ^[6]

作者单位： Division of Oncology, Department of Medicine, Huntsman Cancer Institute, 2000 Circle of Hope Dr., Salt Lake City, UT 84112, USA. ^[1] Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL 32224, USA. ^[2] Eurobiodev, 2040 Avenue du Père Soulas, 34000 Montpellier, France. ^[3] Centre Hospitalier Princesse Grace, 1 Avenue Pasteur, Principauté de Monaco, 98000 Monaco, Monaco. ^[4] Laboratoire de Biochimie et Biologie Moleculaire, CITOHL, Centre Hospitalier Lyon-Sud, 69310 Pierre-Bénite, France. ^[5] ECS-Progastrin, Chemin de la Meunière 12, 1008 Prilly, Switzerland. ^[6]

关键词 IMDC blood-based prognostic biomarker circulating progastrin hPG80 metastatic renal cell carcinoma (mRCC)

DOI 10.3390/cancers13030375

PMID 33498444

发布时间 2021-02-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交